These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11584383)

  • 41. [Pharmacological treatment of the portal hypertension].
    Castañeda Romero B
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():64-5. PubMed ID: 17471863
    [No Abstract]   [Full Text] [Related]  

  • 42. The preoperative placement of transjugular intrahepatic portosystemic shunt for treatment of a patient with portal hypertension and gastric cancer.
    Rumstadt B; Schilling D
    Hepatogastroenterology; 2008; 55(81):303-4. PubMed ID: 18507130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2005 May; 40(5):491-500. PubMed ID: 16036500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term patency of transjugular intrahepatic portosystemic shunt in a patient with portal vein web.
    Kav T; Peynircioglu B; Balkanci F; Bayraktar Y
    J Clin Gastroenterol; 2009 Sep; 43(8):791-2. PubMed ID: 19471165
    [No Abstract]   [Full Text] [Related]  

  • 46. Vaginal bleeding complicating portal hypertension: a particular entity - report of two cases and review of the literature.
    Orlando G; Goffette P; Geubel A; Lerut J
    Transpl Int; 2005 Dec; 18(12):1382-5. PubMed ID: 16297059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transjugular intrahepatic porto-systemic shunt to relieve refractory ascites in a patient with cirrhosis and portal hypertension.
    Joseph G; George OK; Jayanthi V
    Indian Heart J; 2002; 54(6):731-2. PubMed ID: 12674194
    [No Abstract]   [Full Text] [Related]  

  • 48. Transjugular intrahepatic portosystemic shunts: an update.
    Rosado B; Kamath PS
    Liver Transpl; 2003 Mar; 9(3):207-17. PubMed ID: 12619016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
    Olliff SP
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transjugular intrahepatic portosystemic shunt (TIPS): its time has come.
    Boyer TD
    J Clin Gastroenterol; 2008; 42(5):437-8. PubMed ID: 18344898
    [No Abstract]   [Full Text] [Related]  

  • 51. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study.
    González A; Augustin S; Pérez M; Dot J; Saperas E; Tomasello A; Segarra A; Armengol JR; Malagelada JR; Esteban R; Guardia J; Genescà J
    Hepatology; 2006 Oct; 44(4):806-12. PubMed ID: 17006916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension.
    Boyer TD; Haskal ZJ
    J Vasc Interv Radiol; 2005 May; 16(5):615-29. PubMed ID: 15872315
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
    Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
    Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of adrenergic beta receptor blockaders in gastroenterology].
    Vorob'ev LP; Maev IV
    Klin Med (Mosk); 1988 Jan; 66(1):24-8. PubMed ID: 2896269
    [No Abstract]   [Full Text] [Related]  

  • 55. [Surgical treatment of portal hypertension].
    Wolff M; Hirner A
    Zentralbl Chir; 2005 Jun; 130(3):238-45. PubMed ID: 15965877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of medicine in prevention and treatment of upper gastrointestinal hemorrhage in portal hypertension].
    Wang WM; Wang XG
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):865-7. PubMed ID: 17953825
    [No Abstract]   [Full Text] [Related]  

  • 57. Blocking the bleeding way.
    Blendis L; Wong F
    Gastroenterology; 1998 Jul; 115(1):230-2. PubMed ID: 9649483
    [No Abstract]   [Full Text] [Related]  

  • 58. [Terlipressin in the treatment of portal hypertension].
    Escorsell A; Bosch J
    Gastroenterol Hepatol; 1998 Nov; 21(9):452-8. PubMed ID: 9882938
    [No Abstract]   [Full Text] [Related]  

  • 59. Prevention of portal hypertension and small bowel hemorrhage in dogs treated with verapamil during hemorrhagic shock.
    Whalen GF; Hackel DB; Mikat E
    Circ Shock; 1980; 7(4):399-404. PubMed ID: 6971714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Portal hypertension.
    Lygidakis NJ
    Hepatogastroenterology; 1990 Dec; 37(6):533-4. PubMed ID: 2289764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.